| Year |
Citation |
Score |
| 2019 |
Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM, Kotula JW, Antipov E, Dagon Y, Denney WS, Wagner DA, West KA, Degar AJ, Brennan AM, Miller PF. An engineered Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Science Translational Medicine. 11. PMID 30651324 DOI: 10.1126/Scitranslmed.Aau7975 |
0.306 |
|
| 2019 |
Arroyo S, Tiessen RG, Denney WS, Jin J, van Iersel MP(, Zeitz H, Manning AM, Schipperus MR, Bussel JB. Hyper-Sialylated IgG M254, an Innovative Therapeutic Candidate, Evaluated in Healthy Volunteers and in Patients with Immune Thrombocytopenia Purpura: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Blood. 134: 1090-1090. DOI: 10.1182/Blood-2019-125993 |
0.333 |
|
| 2015 |
Nayak S, Lee D, Arkin S, Martin SW, Heatherington AC, Denney WS, Vicini P, Hua F. A Quantitative Systems Pharmacology Model for the Coagulation Network Describes Biomarker Changes Observed in a Clinical Study with FXa Variant and Predicts Age-Associated Biomarker Variations Blood. 126: 3502-3502. DOI: 10.1182/Blood.V126.23.3502.3502 |
0.333 |
|
| 2014 |
Sharma R, Litchfield J, Atkinson K, Eng H, Amin NB, Denney WS, Pettersen JC, Goosen TC, Di L, Lee E, Pfefferkorn JA, Dalvie DK, Kalgutkar AS. Metabolites in safety testing assessment in early clinical development: a case study with a glucokinase activator. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 1926-39. PMID 25142735 DOI: 10.1124/Dmd.114.060087 |
0.315 |
|
| 2012 |
Reitman ML, Dishy V, Moreau A, Denney WS, Liu C, Kraft WK, Mejia AV, Matson MA, Stoch SA, Wagner JA, Lai E. Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients. Journal of Clinical Pharmacology. 52: 1306-16. PMID 22162541 DOI: 10.1177/0091270011419854 |
0.315 |
|
| 2010 |
Chatterjee MS, Denney WS, Jing H, Diamond SL. Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood. Plos Computational Biology. 6. PMID 20941387 DOI: 10.1371/Journal.Pcbi.1000950 |
0.728 |
|
| 2010 |
Sinclair SR, Kane SA, Van der Schueren BJ, Xiao A, Willson KJ, Boyle J, de Lepeleire I, Xu Y, Hickey L, Denney WS, Li CC, Palcza J, Vanmolkot FH, Depré M, Van Hecken A, et al. Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974). British Journal of Clinical Pharmacology. 69: 15-22. PMID 20078608 DOI: 10.1111/J.1365-2125.2009.03543.X |
0.359 |
|
| 2008 |
Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: amplification of 100 fM circulating tissue factor requires flow. Blood. 111: 3507-13. PMID 18203955 DOI: 10.1182/Blood-2007-08-106229 |
0.619 |
|
| 2006 |
Gosalia DN, Denney WS, Salisbury CM, Ellman JA, Diamond SL. Functional phenotyping of human plasma using a 361-fluorogenic substrate biosensing microarray. Biotechnology and Bioengineering. 94: 1099-110. PMID 16575920 DOI: 10.1002/Bit.20927 |
0.702 |
|
| 2005 |
Lo K, Denney WS, Diamond SL. Stochastic modeling of blood coagulation initiation. Pathophysiology of Haemostasis and Thrombosis. 34: 80-90. PMID 16432310 DOI: 10.1159/000089929 |
0.681 |
|
| 2005 |
Edmondson KE, Denney WS, Diamond SL. Neutrophil-bead collision assay: pharmacologically induced changes in membrane mechanics regulate the PSGL-1/P-selectin adhesion lifetime. Biophysical Journal. 89: 3603-14. PMID 16100264 DOI: 10.1529/Biophysj.105.066134 |
0.629 |
|
| 2005 |
Denney WS, Lo K, Diamond SL. Stochastic modeling of extrinsic blood coagulation dynamics Aiche Annual Meeting, Conference Proceedings. 8744. |
0.539 |
|
| 2005 |
Gosalia DN, Denney WS, Salisbury C, Ellman J, Diamond SL. Enzyme assay microarrays for biomarker detection Aiche Annual Meeting, Conference Proceedings. 8959. |
0.713 |
|
| Show low-probability matches. |